Stock Taper
SCREENER COMPARE ANY 2 STOCKS
PHAR
PHARMING GROUP N.V.
NASDAQ
$11.85
▲ UP 1.46% (0.17)

KEY STATISTICS

Market Cap$838.72 M
52w High$21.34
52w Low$9.62
Dividend Yield—
Frequency—
P/E74.06
Volume10.88K
Shares Out.70.78M

COMPANY

LEADERSHIP

Fabrice Chouraqui
CHIEF EXECUTIVE
Fabrice Chouraqui

ABOUT

SECTOR
Healthcare
WENT PUBLIC
December 23, 2020
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
407

PRICE TARGET

Target High$40.00
Target Low$37.00
Target Median$37.00
Target Consensus$38.00

UPCOMING EARNINGS

DateNov 5, 2026
DayThursday
Rev. Est.$106.06M
NOV
5
THU

PRICE

$11.85 ▲ UP 1.46% (+$0.17)
$11.70$11.85$12.009:30 AM10:35 AM11:40 AM12:44 PM1:49 PM2:54 PM3:59 PM11.85

About Pharming Group N.V.

https://www.pharming.com ↗

Pharming Group N.V. is a biopharmaceutical company developing protein replacement therapies and precision medicines for rare diseases, with products like Ruconest for hereditary angioedema and collaborations with Novartis and Orchard Therapeutics.

INDUSTRY

Biotechnology

A PRODUCT PHARMING GROUP N.V. IS KNOWN FOR

Joenja® (leniolisib)
Joenja® (leniolisib)

Joenja® is the first FDA-approved oral PI3Kδ inhibitor for APDS in patients 12+, marking a significant milestone for Pharming Group with a successful U.S. launch and strong initial patient uptake.

COMPETITORS

COMPETITOR
ARGX COMPARE
BMRN COMPARE
RCKT COMPARE
TAK COMPARE
VRTX COMPARE

Revenue by Geography

MapREGIONFY2022FY2023FY2024FY2025
UNITED STATES— $239.11M $287.15M ▲$361.75M ▲
Europe$4.92M — — —
Rest Of The World Excluding US And Europe$616K — — —

INSTITUTIONAL OWNERSHIP

SHARES OWNED
0.25%
HOLDERS
23
TOP 12 OF 23 · RANKED BY POSITION SIZE
Silverberg Bernstein Capital Management LLC
52.1K sh · $756.13K
Newedge Advisors, LLC
28.9K sh · $510.1K
Cowen Prime Advisors LLC
22.5K sh · $261.66K
Millennium Management LLC
20.4K sh · $360.2K
Citadel Advisors LLC
17.7K sh · $312.58K
Crossmark Global Holdings, Inc.
12.5K sh · $169K
Morgan Stanley
11.5K sh · $159.74K
Cowen Prime Services LLC
6.3K sh · $71K
Knoll Capital Management, LLC
4.1K sh · $56.82K
Eversource Wealth Advisors, LLC
1.4K sh · $7.62K
Nalls Sherbakoff Group, LLC
870 sh · $12.08K
Bnp Paribas Arbitrage, Snc
800 sh · $14.14K

RATINGS SNAPSHOT

Overall rating: B

DCFROEROAD/EP/EP/B
Discounted Cash Flow5
Return On Equity3
Return On Assets4
Debt To Equity2
Price To Earnings1
Price To Book2
Overall Score3

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 2
OUTPERFORM 1
3 GRADES IN THE LAST 12 MONTHS
Canaccord Genuity BUY HC Wainwright & Co. BUY Oppenheimer OUTPERFORM

SECTORS PEERS

PEERPRICE
TNGX$23.88COMPARE
PVLA$142.04COMPARE
SEPN$40.00COMPARE
FTRE$18.39COMPARE
BCAX$23.90COMPARE
KURA$11.89COMPARE
ABUS$5.21COMPARE
EYPT$5.32COMPARE